Perbedaan Pelat Timah Nusantara Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Pelat Timah Nusantara Tbk. diperdagangkan di Rp197 (kapitalisasi pasar 492,05 M, volume 24 jam 3,66 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb). Perbedaan utamanya: Pelat Timah Nusantara Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Pelat Timah Nusantara Tbk. lebih aktif diperdagangkan (3,66 jt vs 592,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| NIKL | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 492,05 M | 172,82 M |
Volume | 3,66 jt | 592,2 rb |
Lot | 36,64 rb | 5,92 rb |
Perputaran | 716,64 jt | 147,05 jt |
Harga Rata-rata | 195,61 | 248,31 |
Nilai Transaksi | 716,64 jt | 147,05 jt |
Harga Ekuilibrium Indikatif | 197 | 254 |
Volume Ekuilibrium Indikatif | 149 | 10 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Pelat Timah Nusantara Tbk (PT Latinusa) was the first company in Indonesia that produces high-quality tinplate with international standards. PT Latinusa was founded on August 19, 1982 under the Company Act No.45, drawn up before Imas Fatimah, SH, and the current majority shareholder is the Japanese consortium consisting of Nippon Steel Corporation, Mitsui Co.. Ltd.., Nippon Steel Trading Co.., And Metal One. Nippon Steel Corporation is also the provider of our main raw material, Tin Mill Black Plate (TMBP), so the availability of raw materials is always guaranteed.
Selengkapnya di halaman NIKL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →